ArticleFrontiers in immunology2017

Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity.

Congcong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.